Cargando…

Intestinal microbiota changes pre- and post-fecal microbiota transplantation for treatment of recurrent Clostridioides difficile infection among Iranian patients with concurrent inflammatory bowel disease

INTRODUCTION: Patients with inflammatory bowel disease (IBD) are at a greater risk for the recurrence of Clostridioides difficile infection (rCDI) that is triggered by intestinal microbiota dysbiosis. Fecal microbiota transplantation (FMT) has emerged as a highly effective therapeutic option for thi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gholam-Mostafaei, Fahimeh Sadat, Azimirad, Masoumeh, Naseri, Kaveh, Nabavi-Rad, Ali, Asadzadeh Aghdaei, Hamid, Shahrokh, Shabnam, Ebrahimi Daryani, Nasser, Yadegar, Abbas, Zali, Mohammad Reza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9998922/ https://www.ncbi.nlm.nih.gov/pubmed/36910213 http://dx.doi.org/10.3389/fmicb.2023.1147945

Ejemplares similares

Curcumin and capsaicin regulate apoptosis and alleviate intestinal inflammation induced by Clostridioides difficile in vitro
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Treatment of Recurrent Clostridioides difficile Infection Using Fecal Microbiota Transplantation in Iranian Patients with Underlying Inflammatory Bowel Disease
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective
por: Raeisi, Hamideh, et al.
Publicado: (2022)

Alterations and Prediction of Functional Profiles of Gut Microbiota After Fecal Microbiota Transplantation for Iranian Recurrent Clostridioides difficile Infection with Underlying Inflammatory Bowel Disease: A Pilot Study
por: Azimirad, Masoumeh, et al.
Publicado: (2022)

Serum procalcitonin levels associate with Clostridioides difficile infection in patients with inflammatory bowel disease
por: Abdehagh, Mohammad, et al.
Publicado: (2021)

Rapid-format recombinant antibody-based methods for the diagnosis of Clostridioides difficile infection: Recent advances and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2022)

How Does COVID-19 Pandemic Impact on Incidence of Clostridioides difficile Infection and Exacerbation of Its Gastrointestinal Symptoms?
por: Azimirad, Masoumeh, et al.
Publicado: (2021)

Clostridioides difficile ribotypes 001 and 126 were predominant in Tehran healthcare settings from 2004 to 2018: a 14-year-long cross-sectional study
por: Azimirad, Masoumeh, et al.
Publicado: (2020)

Emerging applications of phage therapy and fecal virome transplantation for treatment of Clostridioides difficile infection: challenges and perspectives
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Clostridioides difficile
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Intestinal Microbiota in Elderly Inpatients with Clostridioides difficile Infection
por: Vakili, Bahareh, et al.
Publicado: (2020)

The double-edged sword of probiotic supplementation on gut microbiota structure in Helicobacter pylori management
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

Pleiotropic effects of Mentha longifolia L. extract on the regulation of genes involved in inflammation and apoptosis induced by Clostridioides difficile ribotype 001
por: Raeisi, Hamideh, et al.
Publicado: (2023)

Effect of sub-MIC values of metronidazole, ciprofloxacin, and imipenem on the growth and toxin production in Clostridioides difficile
por: Shayegan Mehr, Farahnaz Sadat, et al.
Publicado: (2019)

Immunomodulation and Generation of Tolerogenic Dendritic Cells by Probiotic Bacteria in Patients with Inflammatory Bowel Disease
por: Ghavami, Shaghayegh Baradaran, et al.
Publicado: (2020)

Surface layer protein A from hypervirulent Clostridioides difficile ribotypes induce significant changes in the gene expression of tight junctions and inflammatory response in human intestinal epithelial cells
por: Noori, Maryam, et al.
Publicado: (2022)

Prevalence and characterization of Clostridium perfringens toxinotypes among patients with antibiotic-associated diarrhea in Iran
por: Azimirad, Masoumeh, et al.
Publicado: (2019)

Frequency of toxin genes and antibiotic resistance pattern of Clostridioides difficile isolates in diarrheal samples among hospitalized patients in Hamadan, Iran
por: Shokoohizadeh, Leili, et al.
Publicado: (2021)

The Necessity of Stool Examination in Asymptomatic Carriers as a Strategic Measure to Control Further Spread of SARS-CoV-2
por: Mirjalali, Hamed, et al.
Publicado: (2020)

Gut microbiota and microbiota-based therapies for Clostridioides difficile infection
por: Chopra, Teena, et al.
Publicado: (2023)

The Effects of Vitamins and Micronutrients on Helicobacter pylori Pathogenicity, Survival, and Eradication: A Crosstalk between Micronutrients and Immune System
por: Nabavi-Rad, Ali, et al.
Publicado: (2022)

Genetic diversity of Helicobacter pylori type IV secretion system cagI and cagN genes and their association with clinical diseases
por: Azizimoghaddam, Yasaman, et al.
Publicado: (2023)

Fecal Microbiota of Toxigenic Clostridioides difficile-Associated Diarrhea
por: Hernández, Marta, et al.
Publicado: (2019)

Fecal microbiota transplantation beyond Clostridioides difficile infections
por: Wortelboer, Koen, et al.
Publicado: (2019)

Fecal Microbiota Transplantation beyond Clostridioides Difficile Infection
por: Moon, Chang Mo, et al.
Publicado: (2021)

54101 Characterizing Microbiota Features of Clostridioides difficile Infections
por: Tomkovich, Sarah, et al.
Publicado: (2021)

Microbial ecology between Clostridioides difficile and gut microbiota
por: KAMIYA, Shigeru
Publicado: (2023)

Expression of Main Toll-Like Receptors in Patients with Different Types of Colorectal Polyps and Their Relationship with Gut Microbiota
por: Rezasoltani, Sama, et al.
Publicado: (2020)

The interplay between Helicobacter pylori and the gut microbiota: An emerging driver influencing the immune system homeostasis and gastric carcinogenesis
por: Fakharian, Farzaneh, et al.
Publicado: (2022)

Expression of Toll-Like Receptors 2, 4 and 5 in Relation to Gut Microbiota in Colon Neoplasm Patients with and without Inflammatory Bowel Disease
por: Asadzadeh Aghdaei, Hamid, et al.
Publicado: (2022)

Gut microbiota features associated with Clostridioides difficile colonization in puppies
por: Berry, Alexander S. F., et al.
Publicado: (2019)

Insights into the Role of Human Gut Microbiota in Clostridioides difficile Infection
por: Kachrimanidou, Melina, et al.
Publicado: (2020)

Microbiota-based markers predictive of development of Clostridioides difficile infection
por: Berkell, Matilda, et al.
Publicado: (2021)

Fecal microbiota transplantation for recurrent Clostridioides difficile, safety, and pitfalls
por: Sandhu, Avnish, et al.
Publicado: (2021)

Gut Microbiota Composition Associated with Clostridioides difficile Colonization and Infection
por: Martinez, Elisa, et al.
Publicado: (2022)

Editorial: Gut microbiota and gastrointestinal disorders
por: Yadegar, Abbas, et al.
Publicado: (2022)

Gut microbiota, angiotensin-converting enzyme, celiac disease, and risk of COVID-19 infection: a review
por: Gholam-Mostafaei, Fahimeh Sadat, et al.
Publicado: (2021)

High Prevalence Rate of Microbial Contamination in Patient-Ready Gastrointestinal Endoscopes in Tehran, Iran: an Alarming Sign for the Occurrence of Severe Outbreaks
por: Houri, Hamidreza, et al.
Publicado: (2022)

Erratum for Houri et al., “High Prevalence Rate of Microbial Contamination in Patient-Ready Gastrointestinal Endoscopes in Tehran, Iran: an Alarming Sign for the Occurrence of Severe Outbreaks”
por: Houri, Hamidreza, et al.
Publicado: (2023)

Impacts of H. pylori mixed-infection and heteroresistance on clinical outcomes
por: Alebouyeh, Masoud, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_19mqk8q4m6b5shv4e7r90g5gpm